Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis
Open accessAbstract
CONTEXT: Antidepressant medications represent the best established treatment for major depressive disorder, but there is little evidence that they have a specific pharmacological effect relative to pill placebo for patients with less severe depression. OBJECTIVE: To estimate the relative benefit of medication vs placebo across a wide range of initial symptom severity in patients diagnosed with depression. DATA SOURCES: PubMed, PsycINFO, and the Cochrane Library databases were searched from January 1980 through March 2009, along with references from meta-analyses and reviews. STUDY SELECTION: Randomized placebo-controlled trials of antidepressants approved by the Food and Drug Administration in the treatment of major or minor depressive disorder were selected. Studies were included if their authors provided the requisite original data, they comprised adult outpatients, they included a medication vs placebo comparison for at least 6 weeks, they did not exclude patients on the basis of a placebo washout period, and they used the Hamilton Depression Rating Scale (HDRS). Data from 6 studies (718 patients) were included. DATA EXTRACTION: Individual patient-level data were obtained from study authors. RESULTS: Medication vs placebo differences varied substantially as a function of baseline severity. Among patients with HDRS scores below 23, Cohen d effect sizes for the difference between medication and placebo were estimated to be less than 0.20 (a standard definition of a small effect). Estimates of the magnitude of the superiority of medication over placebo increased with increases in baseline depression severity and crossed the threshold defined by the National Institute for Clinical Excellence for a clinically significant difference at a baseline HDRS score of 25. CONCLUSIONS: The magnitude of benefit of antidepressant medication compared with placebo increases with severity of depression symptoms and may be minimal or nonexistent, on average, in patients with mild or moderate symptoms. For patients with very severe depression, the benefit of medications over placebo is substantial.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Antidepressants have been demonstrated efficient in treating MDD.
“antidepressants have been demonstrated efficient in treating MDD”
From SSRI Treatment Response Prediction in Depression Based on Brain Activation by Emotional Stimuli (2020) · cites this paper as [1]
The Introduction says antidepressants are a standard treatment for MDD and have been shown superior to placebo in controlled trials. But the Discussion qualifies their efficacy: the drug–placebo advantage was large for patients with very severe symptoms and negligible for those with less severe symptoms. The unqualified claim omits that distinction. (LLM, conf=0.86)
Experimental — accuracy not yet measuredFournier and colleagues meta-analysed trials of selective serotonin reuptake inhibitors and estimated the effect size for mild to severe depression ranged from -0.17 to -0.11, which is lower than the effect size for smoking cessation.
“Fournier and colleagues meta-analysed trials of selective serotonin reuptake inhibitors and estimated the effect size.45 For mild to severe depression the effect estimates ranged from -0.17 to -0.11; this is lower than the effect size for smoking cessation.”
From Change in mental health after smoking cessation: systematic review and meta-analysis (2014) · cites this paper as [45]
The Methods > Participants passage confirms that Fournier and colleagues pooled trial data and estimated antidepressant effect sizes, but only three of the six trials used the SSRI paroxetine; the other three used the tricyclic antidepressant imipramine. The citation is attached to the first sentence, not the subsequent effect-size range or smoking-cessation comparison. (LLM, conf=0.90)
Experimental — accuracy not yet measuredA substantial portion of the perceived therapeutic benefit of SSRIs in double-blind RCTs may stem from placebo responses rather than the drug itself.
“For SSRIs, researchers have argued that a substantial portion of the perceived therapeutic benefit in double-blind randomized clinical trials (RCTs) may stem from placebo responses rather than the drug itself (Sugarman et al., 2014; Fournier et al., 2010; Kirsch, 2014; Moncrieff and Kirsch, 2015).”
From Revisiting the SSRI vs. placebo debate in the treatment of social anxiety disorder: the role of expectancy effects, neural responsivity, and monoamine transporters (2025) · cites this paper as Fournier et al., 2010
The Results (Drug Class; Baseline Severity and Symptom Change, pages not provided) include trials of the SSRI paroxetine and find that medication’s advantage over placebo was small at lower baseline depression severity. This supports the possibility that much of the observed improvement in those trials was not attributable to the drug, but the citing sentence omits the severity qualification: the paper finds a substantial drug–placebo benefit in patients with very severe depression. Its analysis also includes a non-SSRI antidepressant, so it does not establish the claim for SSRIs generally. (LLM, conf=0.86)
Experimental — accuracy not yet measuredThe introduction and widespread use of SSRI and psychological therapy including CBT meant that well tolerated and effective treatments for depression and anxiety disorders became available in primary care, widening the group of individuals eligible for treatment.
“The introduction and widespread use of selective serotonine uptake inhibitors (SSRI) [22, 23] and psychological therapy including cognitive behavioral therapy (CBT) [24, 25] meant that well tolerated and effective treatments for depression and anxiety disorders became available in primary care, widening the group of individuals eligible for treatment.”
From Trends in psychiatric diagnoses, medications and psychological therapies in a large Swedish region: A population-based study (2020) · cites this paper as [23]
Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredThere are differences in individual response to antidepressants.
“there are differences in individual response”
From SSRI Treatment Response Prediction in Depression Based on Brain Activation by Emotional Stimuli (2020) · cites this paper as [1]
Effect sizes in this study are generally higher than those for pharmacological treatment of mild-to-moderate depression.
“In addition, the effect sizes are generally higher than those obtained for pharmacological treatment of mild-to-moderate depression [34]”
From One-Day Acceptance and Commitment Therapy Compared to Support for Depressed Migraine Patients: a Randomized Clinical Trial. (2020) · cites this paper as [34]
Two individual participant data meta-analyses indicated that patients with lower baseline severity achieve smaller improvement compared to placebo.
“Two individual participant data meta-analysis (26, 27) indicated that patients with lower baseline severity would achieve smaller improvement compared to placebo.”
Individual-level meta-analyses have found a direct relationship between the magnitude of depressive symptoms and the effectiveness of antidepressants.
“Individual-level meta-analyses have found a direct relationship between the magnitude of depressive symptoms and the effectiveness of antidepressants.8–10”
The benefits of antidepressants in non-severe depression have been argued to be minimal.
“Thus, the benefits of antidepressants in non-severe depression have been argued to be minimal.8 11”
One small individual patient data meta-analysis found support for increasing benefit with increasing severity of depression, but three larger individual patient data meta-analyses did not find any such effect of antidepressants compared with placebo on depression severity.
“One small individual patient data meta-analysis found support for increasing benefit with increasing severity of depression,20 but three larger individual patient data meta-analyses did not find any such effect of antidepressants compared with placebo on depression severity .44–46”
From Should antidepressants be used for major depressive disorder? (2020) · cites this paper as [20]
Clinically significant benefits of antidepressants are only observed at "very severe" levels of impairment.
“For example, meta-analysis has demonstrated that antidepressants, though widely prescribed as a treatment for MDD, may be no more effective than placebo for mild to moderate levels of symptom severity; clinically significant benefits are only observed at “very severe” levels of impairment (18).”
From Depression in diabetes: have we been missing something important? (2011) · cites this paper as [18]
Antidepressants may be no more effective than placebo for mild to moderate levels of symptom severity.
“For example, meta-analysis has demonstrated that antidepressants, though widely prescribed as a treatment for MDD, may be no more effective than placebo for mild to moderate levels of symptom severity; clinically significant benefits are only observed at “very severe” levels of impairment (18).”
From Depression in diabetes: have we been missing something important? (2011) · cites this paper as [18]
Although antidepressants are unlikely to be effective in most presentations of distress, physical activity, psychotherapeutic approaches, and discussions with diabetes team members can be effective.
“Although antidepressants are unlikely to be effective in most presentations of distress (18), physical activity, psychotherapeutic approaches, and discussions with diabetes team members can be effective.”
From Depression in diabetes: have we been missing something important? (2011) · cites this paper as [18]
The association between smoking cessation and change in depression and anxiety was equal to or larger than the estimate from trials of antidepressants versus placebo.
“The strength of the pooled standardised mean difference in change was clinically important - the association between smoking cessation and change in depression and anxiety was equal to or larger than the estimate from trials of antidepressants versus placebo.”
From An application of the stress-diathesis model: A review about the association between smoking tobacco, smoking cessation, and mental health (2023) · cites this paper as Fournier et al., 2010
Antidepressants resulted in improved depression symptoms for people with "mild" depression, SMD −0·11 [95% CI: −0·26 to −0·04], and improved depression symptoms in people with "severe" depression, SMD −0·47 [95% CI: −0·59 to −0·34].
“A meta-analysis of individual-level data from randomised controlled trials (RCTs) of antidepressants for”
From An application of the stress-diathesis model: A review about the association between smoking tobacco, smoking cessation, and mental health (2023) · cites this paper as Fournier et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,588 · see citing works
Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,406 · see citing works
Statistical Power Analysis for the Behavioral Sciences (2nd ed.).
Lachenbruch, P. A., & Cohen, J. (1989) · Journal of the American Statistical Association · doi:10.2307/2290095 · Cited by 37,385 · see citing works
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · see citing works
Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442 · see citing works
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435 · see citing works
Elkin, I. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110013002 · Cited by 2,300 · see citing works
Dimidjian, S., Hollon, S. D., Dobson, K. S., Schmaling, K. B., Kohlenberg, R. J., Addis, M. E., Gallop, R., McGlinchey, J. B., Markley, D. K., Gollan, J. K., et al. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.4.658 · Cited by 1,607 · see citing works
Self-citationOstwald, P. F. (1960) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1960.14.4.817 · Cited by 1,422 · see citing works
The Hamilton Depression Rating Scale: Has the Gold Standard Become a Lead Weight?
Bagby, R. M., Ryder, A. G., Schuller, D. R., & Marshall, M. B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.12.2163 · Cited by 1,148 · see citing works
Cognitive Therapy vs Medications in the Treatment of Moderate to Severe Depression
DeRubeis, R. J., Hollon, S. D., Amsterdam, J. D., Shelton, R. C., Young, P. R., Salomon, R. M., O’Reardon, J. P., Lovett, M. L., Gladis, M. M., Brown, L. L., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.409 · Cited by 989 · see citing works
Self-citationSize of Treatment Effects and Their Importance to Clinical Research and Practice
KRAEMER, H. C., & Kupfer, D. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.014 · Cited by 850 · see citing works
Handbook of Psychiatric Measures
Rush, A. J., First, M. B., & Blacker, D. (2000) · Medical Entomology and Zoology · Cited by 846 · see citing works
Treatment and prevention of depression
Hollon, S. D., Thase, M. E., & Markowitz, J. C. (2002) · Psychological Science in the Public Interest · doi:10.1111/1529-1006.00008 · Cited by 511 · see citing works
Self-citationMynors‐Wallis, L., Gath, D. H., Lloyd-Thomas, A. R., & Tomlinson, D. (1995) · BMJ · doi:10.1136/bmj.310.6977.441 · Cited by 491 · see citing works
Khan, A., Leventhal, R. M., Khan, S. R., & Brown, W. A. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200202000-00007 · Cited by 456 · see citing works
A pooled analysis of two placebo-controlled trials of desvenlafaxine in major depressive disorder
Lieberman, D. Z., Montgomery, S., Tourian, K. A., Brisard, C., Rosas, G. R., Padmanabhan, K., Germain, J., & Pitrosky, B. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32830263de · Cited by 214 · see citing works
Philipp, M., Kohnen, R., Hiller, K.-O., Linde, K., & Berner, M. (1999) · BMJ · doi:10.1136/bmj.319.7224.1534 · Cited by 209 · see citing works
Barrett, J. E., Williams, J. W., Oxman, T. E., Frank, E., Katon, W. J., Sullivan, M. D., Hegel, M. T., Cornell, J. E., & Sengupta, A. (2001) · PubMed · Cited by 181 · see citing works
Does a Placebo Run-In or a Placebo Treatment Cell Affect the Efficacy of Antidepressant Medications?
Trivedi, M. H., & Rush, A. J. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.63 · Cited by 176 · see citing works
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
THIERS, B. H. (2009) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)79042-7 · Cited by 157 · see citing works
STEINBERG, K. K., Smith, S. J., Stroup, D. F., Olkin, I., Lee, N. C., Williamson, G. D., & Thacker, S. B. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009051 · Cited by 151 · see citing works
Wichers, M. C., Barge-Schaapveld, D. Q. C. M., Nicolson, N. A., Peeters, F., de Vries, M., Mengelers, R., & van Os, J. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.66 · Cited by 139 · see citing works
Liebowitz, M. R., Manley, A. L., Padmanabhan, S. K., Ganguly, R., Tummala, R., & Tourian, K. A. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802161923 · Cited by 134 · see citing works
Benjamin, L. S. (1963) · Psychosomatic Medicine · doi:10.1097/00006842-196311000-00005 · Cited by 128 · see citing works
Treatment of depression--newer pharmacotherapies.
Mulrow, C. D., Williams, J. W., Trivedi, M. H., Chiquette, E., Aguilar, C., Cornell, J. E., Badgett, R. G., Noël, P. H., Lawrence, V. A., Lee, S., et al. (1999) · PubMed Central · Cited by 124 · see citing works
Boyer, P., Montgomery, S., Lepola, U. M., Germain, J., Brisard, C., Ganguly, R., Padmanabhan, S. K., & Tourian, K. A. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32830cebed · Cited by 124 · see citing works
Lee, S., Walker, J. R., Jakul, L., & Sexton, K. A. (2004) · Depression and Anxiety · doi:10.1002/da.10134 · Cited by 109 · see citing works
DeMartinis, N. A., Yeung, P. P., Entsuah, R., & Manley, A. L. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0504 · Cited by 108 · see citing works
Septien-Velez, L., Pitrosky, B., Padmanabhan, S. K., Germain, J., & Tourian, K. A. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3281e2c84b · Cited by 96 · see citing works
Acute and maintenance treatment of chronic depression.
Dünner, D. L. (2001) · PubMed · Cited by 92 · see citing works
Selegiline Transdermal System for the Treatment of Major Depressive Disorder
Feiger, A. D., Rickels, K., Rynn, M. A., ZIMBROFF, D. L., & Robinson, D. S. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0905 · Cited by 88 · see citing works
Gastpar, M., Singer, A., & Zeller, K. (2006) · Pharmacopsychiatry · doi:10.1055/s-2006-931544 · Cited by 86 · see citing works
Versiani, M., Oggero, U., Alterwain, P., Capponi, R., Dajas, F., Heinze-Martin, G., Marquez, C., Poleo, M. A., Rivero-Almanzor, L. E., Rossel, L., et al. (1989) · The British Journal of Psychiatry · doi:10.1192/s0007125000297523 · Cited by 81 · see citing works
Liebowitz, M. R., & Yeung, P. P. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n1105 · Cited by 73 · see citing works
Cohn, C. K., Robinson, D. S., Roberts, D. L., SCHWIDERSKI, U. E., O'Brien, K., & Ieni, J. R. (1996) · PubMed · Cited by 67 · see citing works
Chronicity of depressive episode in relation to antidepressant-placebo response.
Khan, A., Dager, S. R., Cohen, S., Avery, D., Scherzo, B., & Dünner, D. L. (1991) · PubMed · Cited by 62 · see citing works
Zimmerman, M. A., Posternak, M. A., & Chelminski, I. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000155824.59585.46 · Cited by 58 · see citing works
Double-blind placebo-controlled trial of amitriptyline among depressed patients in general practice.
Hollyman, J. A., FREELING, P., Paykel, E. S., Bhat, A., & Sedgwick, P. M. (1988) · Europe PMC (PubMed Central) · Cited by 57 · see citing works
The Impact of Restrictive Entry Criterion During the Placebo Lead‐in Period
Landin, R., DeBrota, D. J., DeVries, T. A., Potter, W. Z., & Demitrack, M. A. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00271.x · Cited by 57 · see citing works
Efficacy of reversible inhibitors of monoamine oxidase‐A in various forms of depression
Lecrubier, Y., & Guelfi, J. D. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb05319.x · Cited by 53 · see citing works
Symptom Severity and Exclusion From Antidepressant Efficacy Trials
Zimmerman, M., Posternak, M. A., & Chelminski, I. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200212000-00011 · Cited by 49 · see citing works
The efficacy of drug treatments for dysthymia: a systematic review and meta-analysis
de Lima, M. S., HOTOPH, M., & Wessely, S. C. (1999) · Psychological Medicine · doi:10.1017/s0033291799001324 · Cited by 48 · see citing works
Drug effects and initial severity of symptomatology
Fisher, S., Lipman, R. S., UHLENHUTH, E. H., Rickels, K., & Park, L. C. (1965) · Psychopharmacology · doi:10.1007/bf00404165 · Cited by 33 · see citing works
Placebo-controlled dose-ranging trial designs in phase II development of nefazodone.
D’Amico, M. F., Roberts, D. L., Robinson, D. S., SCHWIDERSKI, U. E., & Copp, J. (1990) · PubMed · Cited by 31 · see citing works
Ad, F. (1996) · PubMed · Cited by 28 · see citing works
Trazodone in depressed outpatients
Rickels, K., & CASE, W. G. (1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.6.803 · Cited by 27 · see citing works
Lofepramine and imipramine in unipolar depressed outpatients
Rickels, K., Weise, C. C., Zal, H. M., Csanalosi, I., & Werblowsky, J. H. (1982) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1982.tb00919.x · Cited by 15 · see citing works
A multicentre comparative trial of moclobemide, imipramine and placebo in major depressive disorder
Silverstone, T. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199400920-00007 · Cited by 14 · see citing works
Ballenger, J. C. (2008) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)70775-8 · Cited by 13 · see citing works
Baldwin, D. S., Rudge, S., & Thomas, S. C. (1995) · CNS Drugs · doi:10.2165/00023210-199504060-00005 · Cited by 11 · see citing works
Assessing treatment response to the monoamine oxidase inhibitor isocarboxazid.
Giller, E. L., Bialos, D., Harkness, L., & Riddle, M. A. (1984) · PubMed · Cited by 11 · see citing works
Moclobemide, imipramine and placebo in the treatment of major depression
Versiani, M., Nardi, A. E., Mundim, F. D., Alves, A., & Schmid‐Burgk, W. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb05331.x · Cited by 8 · see citing works
Trazodone in depressed outpatients
Rickels, K., & CASE, W. G. (1982) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198212000-00020 · Cited by 3 · see citing works
Flagged first, then by citations
2 of the 56 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- [3]Depression Guideline Panel Depression in primary care: Vol. 2. Treatment of major depression Clinical Practice Guideline No. 5. AHCPR Publication No. 93-0551 Rockville, MD U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research 1993
Cited by
Sorted by citations
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,361 · see citing works
Meditation Programs for Psychological Stress and Well-being: A Systematic Review and Meta-analysis
Goyal, M., Singh, S., Sibinga, E. M. S., Gould, N. F., Rowland-Seymour, A., Sharma, R., Berger, Z., Sleicher, D., Maron, D. D., Shihab, H. M., et al. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.13018 · Cited by 2,380 · see citing works
Blumberger, D. M., Vila-Rodriguez, F., Thorpe, K. E., Feffer, K., Noda, Y., Giacobbe, P., Knyahnytska, Y., Kennedy, S. H., Lam, R. W., Daskalakis, Z. J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30295-2 · Cited by 1,363 · see citing works
Andrews, G., Cuijpers, P., Craske, M. G., McEvoy, P., & Titov, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013196 · Cited by 1,311 · see citing works
PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,372 · see citing works
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial
Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., Finan, P. H., & Griffiths, R. R. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.3285 · Cited by 1,301 · see citing works
Severity classification on the Hamilton depression rating scale
Zimmerman, M., Martinez, J. H., Young, D., Chelminski, I., & Dalrymple, K. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.04.028 · Cited by 1,199 · see citing works
Non-psychotic mental disorders in the perinatal period
Howard, L. M., Molyneaux, E., Dennis, C.-L., Rochat, T., Stein, A., & Milgrom, J. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61276-9 · Cited by 1,328 · see citing works
Change in mental health after smoking cessation: systematic review and meta-analysis
Taylor, G., McNeill, A., Girling, A., Farley, A., Lindson-Hawley, N., & Aveyard, P. (2014) · BMJ · doi:10.1136/bmj.g1151 · Cited by 1,039 · see citing works
The GABAergic deficit hypothesis of major depressive disorder
Luscher, B., Shen, Q., & Sahir, N. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.120 · Cited by 934 · see citing works
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842 · see citing works
The Origins and Current Status of Behavioral Activation Treatments for Depression
Dimidjian, S., Barrera, M., Martell, C., Muñoz, R. F., & Lewinsohn, P. M. (2011) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032210-104535 · Cited by 785 · see citing works
Self-citationCleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759 · see citing works
Seppi, K., Weintraub, D., Coelho, M., Perez‐Lloret, S., Fox, S. H., Katzenschlager, R., Hametner, E., Poewe, W., Rascol, O., Goetz, C. G., et al. (2011) · Movement Disorders · doi:10.1002/mds.23884 · Cited by 1,141 · see citing works
Bauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632 · see citing works
Hu, Y., Li, C., Wang, X., Yang, Y., & Zhu, H. (2014) · Chemical Reviews · doi:10.1021/cr400131u · Cited by 613 · see citing works
Barone, P., Poewe, W., Albrecht, S., Debieuvre, C., Massey, D., Rascol, O., Tolosa, E., & Weintraub, D. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70106-x · Cited by 562 · see citing works
Cognitive Mechanisms of Treatment in Depression
Roiser, J. P., Elliott, R., & Sahakian, B. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.183 · Cited by 535 · see citing works
Safety and Efficacy of Sertraline for Depression in Patients With Heart Failure
O'Connor, C. M., Jiang, W., Kuchibhatla, M., Silva, S. G., Cuffe, M. S., Callwood, D. D., Zakhary, B., Stough, W. G., Arias, R. M., Rivelli, S. K., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.068 · Cited by 535 · see citing works
Beck, A. T., & Bredemeier, K. (2016) · Clinical Psychological Science · doi:10.1177/2167702616628523 · Cited by 510 · see citing works
Gordon, B. R., McDowell, C. P., Hallgren, M., Meyer, J. D., Lyons, M., & Herring, M. P. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0572 · Cited by 498 · see citing works
McCarron, R. M., Shapiro, B. B., Rawles, J., & Luo, J. S. (2021) · Annals of Internal Medicine · doi:10.7326/aitc202105180 · Cited by 500 · see citing works
Wastewater-based epidemiology biomarkers: Past, present and future
Choi, P. M., Tscharke, B. J., Donner, E., O'Brien, J. W., Grant, S. C., Kaserzon, S. L., Mackie, R., O'Malley, E., Crosbie, N. D., Thomas, K. V., et al. (2018) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2018.06.004 · Cited by 486 · see citing works
Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial.
Kanes, S., Colquhoun, H., Gunduz-Bruce, H., Raines, S., Arnold, R., Schacterle, A., Doherty, J., Epperson, C. N., Deligiannidis, K. M., Riesenberg, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31264-3 · Cited by 479 · see citing works
Psychiatry beyond the current paradigm
Bracken, P., Thomas, P., Timimi, S., Asen, E., Behr, G., Beuster, C., Bhunnoo, S., Browne, I., Chhina, N., Double, D., et al. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.109447 · Cited by 474 · see citing works
Sarris, J. J., Panossian, A. G., Schweitzer, I., Stough, C. K. K., & Scholey, A. B. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.04.002 · Cited by 479 · see citing works
Depression in the Primary Care Setting
Park, L. T., & Zarate, C. A. (2019) · New England Journal of Medicine · doi:10.1056/nejmcp1712493 · Cited by 474 · see citing works
Treatment selection in depression.
Cohen, Z. D., & DeRubeis, R. J. (2018) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050817-084746 · Cited by 435 · see citing works
Self-citationVaccarino, V., Badimon, L., Bremner, J. D., Cenko, E., Cubedo, J., Dorobantu, M., Duncker, D. J., Koller, A., Manfrini, O., Milicic, D., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehy913 · Cited by 404 · see citing works
Fu, C. H. Y., Steiner, H., & Costafreda, S. G. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.05.008 · Cited by 399 · see citing works
Dichter, G. S., Gibbs, D., & Smoski, M. J. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.09.028 · Cited by 375 · see citing works
Jesulola, E., Micalos, P., & Baguley, I. J. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.025 · Cited by 379 · see citing works
The efficacy of non-directive supportive therapy for adult depression: A meta-analysis
Cuijpers, P., Driessen, E., Hollon, S. D., van Oppen, P., Barth, J., & Andersson, G. (2012) · Clinical Psychology Review · doi:10.1016/j.cpr.2012.01.003 · Cited by 369 · see citing works
Self-citationJakobsen, J. C., Katakam, K. K., Schou, A., Hellmuth, S. G., Stallknecht, S. E., Leth-Møller, K., Iversen, M., Banke, M. B., Petersen, I. J., Klingenberg, S. L., et al. (2017) · BMC Psychiatry · doi:10.1186/s12888-016-1173-2 · Cited by 366 · see citing works
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365 · see citing works
Personalized Medicine for Depression: Can We Match Patients With Treatments?
Simon, G. E., & Perlis, R. H. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09111680 · Cited by 365 · see citing works
Herring, M. P. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.696 · Cited by 362 · see citing works
Neuropsychiatric outcomes of stroke
Hackett, M. L., Köhler, S., O'Brien, J. T., & Mead, G. E. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70016-x · Cited by 351 · see citing works
Causal machine learning for predicting treatment outcomes
Feuerriegel, S., Frauen, D., Melnychuk, V., Schweisthal, J., Heß, K., Curth, A., Bauer, S., Kilbertus, N., Kohane, I. S., & van der Schaar, M. (2024) · Nature Medicine · doi:10.1038/s41591-024-02902-1 · Cited by 353 · see citing works
Burnout and Depression: Two Entities or One?
Schonfeld, I. S., & Bianchi, R. (2016) · Journal of Clinical Psychology · doi:10.1002/jclp.22229 · Cited by 345 · see citing works
Gardner, A., & Boles, R. G. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.030 · Cited by 333 · see citing works
Brakowski, J., Spinelli, S., Doerig, N., Bosch, O. G., Manoliu, A., Holtforth, M. G., & Seifritz, E. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.04.007 · Cited by 326 · see citing works
National Trends in Outpatient Psychotherapy
Olfson, M., & Marcus, S. C. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10040570 · Cited by 315 · see citing works
Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline
Grassi, L., Caruso, R., Riba, M. B., Lloyd-Williams, M., Kissane, D., Rodin, G., McFarland, D., Campos-Ródenas, R., Zachariae, R., Santini, D., et al. (2023) · ESMO Open · doi:10.1016/j.esmoop.2023.101155 · Cited by 316 · see citing works
National trends in the treatment for depression from 1998 to 2007
Marcus, S. C., & Olfson, M. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.151 · Cited by 312 · see citing works
Depression in diabetes: have we been missing something important?
Gonzalez, J. S., Fisher, L., & Polonsky, W. H. (2011) · Diabetes Care · doi:10.2337/dc10-1970 · Cited by 302 · see citing works
An electroencephalographic signature predicts antidepressant response in major depression
Wu, W., Zhang, Y., Jiang, J., Lucas, M. V., Fonzo, G. A., Rolle, C. E., Cooper, C., Chin-Fatt, C., Krepel, N., Cornelssen, C. A., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0397-3 · Cited by 302 · see citing works
The Initial Field Trials of DSM-5: New Blooms and Old Thorns
Freedman, R., Lewis, D. A., Michels, R., Pine, D. S., Schultz, S. K., Tamminga, C. A., Gabbard, G. O., Gau, S. S.-F., Javitt, D. C., Oquendo, M. A., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12091189 · Cited by 295 · see citing works
Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis
Bloch, M. H., & Hannestad, J. O. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.100 · Cited by 293 · see citing works
Severity of Depression and Magnitude of Productivity Loss
Beck, A., Crain, A. L., Solberg, L. I., Unutzer, J., Glasgow, R. E., Maciosek, M. V., & Whitebird, R. (2011) · The Annals of Family Medicine · doi:10.1370/afm.1260 · Cited by 290 · see citing works
A systematic review of comparative efficacy of treatments and controls for depression
Khan, A., Faucett, J., Lichtenberg, P., Kirsch, I., & Brown, W. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041778 · Cited by 288 · see citing works
Nelson, J. C., & Devanand, D. P. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03355.x · Cited by 284 · see citing works
Neuroplasticity Underlying the Comorbidity of Pain and Depression
Doan, L., Manders, T. R., & Wang, J. (2015) · Neural Plasticity · doi:10.1155/2015/504691 · Cited by 284 · see citing works
Andrews, P. W., Bharwani, A., Lee, K. R., Fox, M., & Thomson, J. A. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.01.018 · Cited by 281 · see citing works
Guidelines for Rehabilitation in Patients With Cardiovascular Disease (JCS 2012)
JCS Joint Working Group (2014) · Circulation Journal · doi:10.1253/circj.cj-66-0094 · Cited by 283 · see citing works
Detecting Depression Severity from Vocal Prosody
Yang, Y., Fairbairn, C., & Cohn, J. F. (2013) · IEEE Transactions on Affective Computing · doi:10.1109/t-affc.2012.38 · Cited by 280 · see citing works
Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review
Molero, P., Ramos-Quiroga, J. A., Martin-Santos, R., Calvo-Sánchez, E., Gutiérrez-Rojas, L., & Meana, J. J. (2018) · CNS Drugs · doi:10.1007/s40263-018-0519-3 · Cited by 280 · see citing works
Cognitive Behavioural Therapy for Insomnia (CBT-I) to treat depression: a systematic review
Cunningham, J. E. A., & Shapiro, C. M. (2018) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.12.012 · Cited by 278 · see citing works
Johansson, R., Sjöberg, E., Sjögren, M., Johnsson, E., Carlbring, P., Andersson, T., Rousseau, A., & Andersson, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036905 · Cited by 268 · see citing works
Antidepressants Normalize the Default Mode Network in Patients With Dysthymia
Posner, J., Hellerstein, D. J., Gat, I., Mechling, A., Klahr, K., Wang, Z., McGrath, P. J., Stewart, J. W., & Peterson, B. S. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.455 · Cited by 268 · see citing works
Kazdin, A. E. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108993647.010 · Cited by 279 · see citing works
Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil.
Thobois, S., Lhommée, E., Klinger, H., Ardouin, C., Schmitt, E., Bichon, A., Kistner, A., Castrioto, A., Xie, J., Fraix, V., et al. (2013) · Brain : a journal of neurology · doi:10.1093/brain/awt067 · Cited by 258 · see citing works
A Model of Placebo Response in Antidepressant Clinical Trials
Rutherford, B. R., & Roose, S. P. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12040474 · Cited by 268 · see citing works
Gibbons, R. D., Hur, K., Brown, C. H., Davis, J. M., & Mann, J. J. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2044 · Cited by 271 · see citing works
Cooper, A. A., & Conklin, L. R. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.05.001 · Cited by 264 · see citing works
Cuijpers, P., Turner, E. H., Koole, S. L., van Dijke, A., & Smit, F. (2014) · Depression and Anxiety · doi:10.1002/da.22249 · Cited by 242 · see citing works
Ly, K. H., Trüschel, A., Jarl, L., Magnusson, S., Windahl, T., Johansson, R., Carlbring, P., & Andersson, G. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-003440 · Cited by 269 · see citing works
A review of empirically supported psychological therapies for mood disorders in adults
Hollon, S. D., & Ponniah, K. (2010) · Depression and Anxiety · doi:10.1002/da.20741 · Cited by 267 · see citing works
Self-citationPursuing happiness in everyday life: The characteristics and behaviors of online happiness seekers.
Parks, A. C., Porta, M. D. D., Pierce, R. S., Zilca, R., & Lyubomirsky, S. (2012) · Emotion · doi:10.1037/a0028587 · Cited by 277 · see citing works
Increasing placebo responses over time in U.S. clinical trials of neuropathic pain
Tuttle, A. H., Tohyama, S., Ramsay, T., Kimmelman, J., Schweinhardt, P., Bennett, G. J., & Mogil, J. S. (2015) · Pain · doi:10.1097/j.pain.0000000000000333 · Cited by 262 · see citing works
Blumenthal, J. A., Sherwood, A., Babyak, M. A., Watkins, L. L., Smith, P. J., Hoffman, B. M., O'Hayer, C. V. F., Mabe, S., Johnson, J., Doraiswamy, P. M., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.040 · Cited by 259 · see citing works
Proportion Of Antidepressants Prescribed Without A Psychiatric Diagnosis Is Growing
Mojtabai, R., & Olfson, M. (2011) · Health Affairs · doi:10.1377/hlthaff.2010.1024 · Cited by 252 · see citing works
Pearce, M., Koenig, H. G., Robins, C. J., Nelson, B., Shaw, S. F., Cohen, H. J., & King, M. (2014) · Psychotherapy · doi:10.1037/a0036448 · Cited by 267 · see citing works
Efficacy of Antimanic Treatments: Meta-analysis of Randomized, Controlled Trials
Yıldız, A., Vieta, E., Leucht, S., & Baldessarini, R. J. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.192 · Cited by 251 · see citing works
GENDEP Investigators, MARS Investigators, STAR*D Investigators, Uher, R., Tansey, K. E., Henigsberg, N., Wolfgang, M. C., Mors, O. N., Hauser, J., Placentino, A., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12020237 · Cited by 241 · see citing works
Driessen, E., Van, H. L., Don, F. J., Peen, J., Kool, S., Westra, D., Hendriksen, M., Schoevers, R. A., Cuijpers, P., Twisk, J. W. R., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12070899 · Cited by 241 · see citing works
Nettis, M. A., Lombardo, G., Hastings, C., Zajkowska, Z., Mariani, N., Nikkheslat, N., Worrell, C., Enache, D., McLaughlin, A., Kose, M., et al. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-020-00948-6 · Cited by 235 · see citing works
Mistreating Psychology in the Decades of the Brain
Miller, G. A. (2010) · Perspectives on Psychological Science · doi:10.1177/1745691610388774 · Cited by 243 · see citing works
Evidence‐based treatment of depression in patients with cancer
Li, M., Fitzgerald, P., & Rodin, G. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.7372 · Cited by 236 · see citing works
van Marwijk, H., Allick, G., Wegman, F., Bax, A., & Riphagen, I. I. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007139.pub2 · Cited by 233 · see citing works
Prévot, T. D., & Sibille, E. L. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0727-3 · Cited by 232 · see citing works
The Promise of Heart Rate Variability Biofeedback: Evidence-Based Applications
Gevirtz, R. (2013) · Biofeedback · doi:10.5298/1081-5937-41.3.01 · Cited by 225 · see citing works
Grady, D. G. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.90 · Cited by 229 · see citing works
Network Meta-Analysis and Cost-Effectiveness Analysis of New Generation Antidepressants
Khoo, A. L., Zhou, H. J., Teng, M., Lin, L., Zhao, Y. J., Soh, L. B., Mok, Y. M., Lim, B. P., & Gwee, K. P. (2015) · CNS Drugs · doi:10.1007/s40263-015-0267-6 · Cited by 230 · see citing works
The severity of psychiatric disorders
Zimmerman, M., Morgan, T. A., & Stanton, K. (2018) · World Psychiatry · doi:10.1002/wps.20569 · Cited by 227 · see citing works
Probiotic modulation of the microbiota-gut-brain axis and behaviour in zebrafish
Borrelli, L., Aceto, S., Agnisola, C., De Paolo, S., Dipineto, L., Stilling, R. M., Dinan, T. G., Cryan, J. F., Menna, L. F., & Fioretti, A. (2016) · Scientific Reports · doi:10.1038/srep30046 · Cited by 225 · see citing works
How evidence‐based medicine is failing due to biased trials and selective publication
Every‐Palmer, S., & Howick, J. (2014) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12147 · Cited by 228 · see citing works
Baumeister, H., Hutter, N., & Bengel, J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008012.pub3 · Cited by 220 · see citing works
Rethinking recommendations for screening for depression in primary care
Thombs, B. D., Coyne, J. C., Cuijpers, P. J., de Jonge, P., Gilbody, S. M., Ioannidis, J. P. A., Johnson, B. T., Patten, S. B., Turner, E. H., & Ziegelstein, R. C. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.111035 · Cited by 221 · see citing works
Barbui, C., Cipriani, A., Patel, V., Ayuso‐Mateos, J. L., & van Ommeren, M. (2011) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.109.076448 · Cited by 216 · see citing works
Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011
Stephenson, C. P., Karanges, E., & McGregor, I. S. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412466595 · Cited by 217 · see citing works
Furukawa, T. A., Salanti, G., Atkinson, L. Z., Leucht, S., Ruhe, H. G., Turner, E. H., Chaimani, A., Ogawa, Y., Takeshima, N., Hayasaka, Y., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010919 · Cited by 214 · see citing works
Luo, Y., Kataoka, Y., Ostinelli, E. G., Cipriani, A., & Furukawa, T. A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00035 · Cited by 206 · see citing works
Urgent need for improved mental health care and a more collaborative model of care
Lake, J., & Turner, M. S. (2017) · The Permanente Journal · doi:10.7812/tpp/17-024 · Cited by 201 · see citing works
Driessen, E., Cuijpers, P., Hollon, S. D., & Dekker, J. J. M. (2010) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0020570 · Cited by 208 · see citing works
Self-citationPlacebo effect in the treatment of depression and anxiety
Kirsch, I. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00407 · Cited by 205 · see citing works
Hieronymus, F., Emilsson, J. F., Nilsson, S., & Eriksson, E. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.53 · Cited by 204 · see citing works
Penn, E., & Tracy, D. K. (2012) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125312445469 · Cited by 207 · see citing works
AB-GEN Collaborative Group, Pérez, V., Salavert, A., Espadaler, J., Tuson, M., Sáiz-Ruiz, J., Sáez-Navarro, C., Bobes, J., Baca‐García, E., Vieta, E., et al. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1412-1 · Cited by 202 · see citing works
A primer on network meta-analysis with emphasis on mental health
Mavridis, D., Giannatsi, M., Cipriani, A., & Salanti, G. (2015) · Evidence Based Mental Health · doi:10.1136/eb-2015-102088 · Cited by 198 · see citing works
- Authors
- Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., & Fawcett, J.
- Affiliations
- University of Pennsylvania (US)
- University of New Mexico (US)
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2010-01-06
- Volume
- 303
- Issue
- 1
- Pages
- 47
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC3712503
- OpenAlex
- W2004762037
- Cited by
- 2,009
- References
- 56
- Citations by year
- 2026: 54 · 2025: 72 · 2024: 89 · 2023: 70 · 2022: 81 · 2021: 134 · 2020: 81 · 2019: 111 · 2018: 143 · 2017: 128 · 2016: 112 · 2015: 149 · 2014: 154 · 2013: 170 · 2012: 172
- FWCI
- 144.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- Sanofi
- National Alliance for Research on Schizophrenia and Depression
- Universiteit Maastricht
- National Institute of Mental Health (K24MH001741, R10 MH50129, R01MH060998, K02MH001697, R10MH055875, R10MH055877)
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- antidepressants, major depressive disorder, depression severity, placebo response, Hamilton Depression Rating Scale, treatment effect heterogeneity, mild depression, antidepressant efficacy
- MeSH terms
- Adult, Antidepressive Agents, Depression, Major Depressive Disorder, Humans, Placebo Effect, Randomized Controlled Trials as Topic, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
